期刊文献+

芩莲正积方抑制Lewis肺癌模型小鼠转移及其机制研究 被引量:3

Study of Qinlian Zhengji Formula Inhibiting Metastasis of Lewis Lung Cancer Model Mouse and Mechanisms
下载PDF
导出
摘要 目的 :观察芩莲正积方对Lewis肺癌小鼠转移的抑制作用,并探讨其机制。方法 :建立Lewis肺癌小鼠模型,芩莲正积方干预,并设对照组,观察各组抑瘤率、肺转移抑制率,采用SABC免疫组化法检测各组CD44含量、实时荧光定量PCR检测各组血管内皮生长因子(vascular endothelial growth factor,VEGF)m RNA表达情况。结果:芩莲正积方组、顺铂组及联合组的抑瘤率分别为18.16%、27.12%、36.37%,芩莲正积方可抑制肺癌转移,降低CD44、VEGF表达,与顺铂联用作用增强。结论:芩莲正积方可抑制Lewis肺癌小鼠转移,其机制可能与降低CD44、VEGF表达相关。 Objective:To observe the effects of Qinlian Zhengji formula on inhibitiing metastasis of Lewis lung cancer mouse,and to discuss its related mechanisms. Methods:Models of lewis lung cancer mouse were established for different groups of intervention. To observe groups of tumor inhibition rate and lung metasta- sis inhibition rate,test groups of CD44 content by immunohistochemical,use real-time fluorescent quantitative PCR technique to detect the expression of VEGF gene. Results:The tumor inhibition rates of Qinlian Zhengji formula group,cisplatin group and combined group were 18.16%,27.12%,36.37%,Qinlian Zhengji formula can inhibit lung cancer metastases,and reduce the expression of CD44 and vascular endothelial growth factor (VEGF) gene expression. It combined cisplatin has synergistic effect. Conclusion:Qinlian Zhengji formula can inhibit metastasis of Lewislung cancer mouse,its mechanisms may be related to its decreasing the expression of CD44 and VEGF.
出处 《山东中医杂志》 2015年第10期780-782,共3页 Shandong Journal of Traditional Chinese Medicine
基金 山东省中医药管理局课题(编号:2009Z003)
关键词 芩莲正积方 肺癌转移 CD44 血管内皮生长因子(VEGF) Qinlian Zhengji formula lung cancer metastasis CD44 vascular endothelial growth factor (VEGF)
  • 相关文献

参考文献8

二级参考文献111

  • 1姜镕,李笑更.超选择性颅内动脉灌注治疗肺癌脑转移[J].中国现代神经疾病杂志,2005,5(5):334-339. 被引量:3
  • 2Lerma E,Romero M,Gallardo A,et al.Prognostic significance of the Fas-recep tor/Fas-ligand system in cervical squamous cell carci-noma[J].Virchows Arch,2005,2(1):211 -22.
  • 3Tee YT,Han CP,Ko JL,et al.Evaluation of matrix metallop rotein-ase-2 expression in cervical carcinogenesis using tissue array and in-tegrated optical density for immunoreactivity[J] Rep rod Sci,2007,14(7):719-26.
  • 4Mizukami Y,Li J,Zhang X,et al.Hypoxia-inducible factor-1 inde-pendent regulation of vascular endothelial growth factor by hypoxia in colon cancer[J].Cancer Res,2004,64(5):1765 -72.
  • 5Bos R,van der Groep P,Greijer AE,et al.Levels of hypoxia-induc-ible factor-1 alpha independently predict prognosis in patients with lymph node negative breast carcinoma[J].Cancer,2003,97 (6):1573-81.
  • 6Buchler P,Reber HA,Buchler M,et al.Hypoxia-inducible factor-1 regulates vascular endothelial growth factor expression in human panereatic cancer[J].Pancreas,2003,26(1):56-64.
  • 7Lee C H,Lee M K,Kang C D,et al.Differential expression of hypox-ia inducible factor 1 alpha and tunor cell proliferation between squa-mous cell carcinomas and adenocarcinomas among operable non-small cell lung carcinomas[J].J Korean Med Sci,2003,18(2):196 -203.
  • 8Buchler P,Reber H A,Buchler M,et al.Hypoxia inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer[J].Pancreas,2003,26(1):56 -64.
  • 9Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 10Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prey, 2010, 19(8): 1893-1907.

共引文献174

同被引文献32

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部